Beardsley Robert A bought ABUS

September 18, 2026 · Form 4 insider transaction

Beardsley Robert A bought 78,800 shares of Arbutus Biopharma Corporation at $4.24 per share, a transaction worth $334.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.